What is Cotard’s Syndrome?

Summary: Cotard’s Syndrome is a neuropsychiatric condition characterized by the belief that one is dead and/or has missing body parts, loss of blood, and or missing organs.

Key Points:

• Cotard’s syndrome (CS) is also called Cotard’s delusion, or, informally, walking corpse syndrome.
• Cotard’s syndrome is not a disease with its own definition or classification in medical or psychiatric manuals, but rather a set of symptoms associated with or caused by separate medical or psychiatric diagnoses.
• In cases with an identifiable cause, treatment can resolve and/or significantly improve the symptoms of CS.
• In cases with severe, treatment-resistant symptoms and/or no clear cause, treatment outcomes may vary, and persist longer than cases with less severe symptoms and an identifiable cause.

Understanding Cotard’s Syndrome

Most medical professionals – including psychiatrists – don’t fully understand CS. This is clear in the abstract from the most recent, peer-reviewed journal article on CS, called “Unlocking the Enigma of Cotard’s Syndrome: A Narrative Review of its Clinical Manifestations and Therapeutic Strategies,” published in 2024:

“Despite its historical origins, CS remains poorly understood and often misdiagnosed.”

To advance our understanding of CS, the study authors conducted a thorough review of the existing scientific literature on CS with this goal:

“ [To] elucidate the clinical complexity, diagnostic challenges, and therapeutic strategies associated with Cotard’s Syndrome.”

We’ll share what they found, starting with their simple definition of the syndrome, which we paraphrase in the introductory summary above:

“The CS is characterized by the false assumption that one is dead, nonexistent, decaying, or has lost vital organs or blood.”

That’s what the disorder is: the mistaken belief that one is dead, or parts of their body is/are missing or dead. It’s rare, with experts estimating the existence of around 200 cases documented worldwide. It occurs more often in people over 50, but may appear in children, adolescents, and adults younger than 50.

Now let’s review the symptoms associated with Cotard’s Syndrome.

How Do the Symptoms of Cotard’s Syndrome Appear?

Studies on CS show that the symptoms occur in three identifiable stages:

1. Germination stage:
   • Symptoms such as sadness/depression with psychosis
   • Hypochondria, i.e. constant worry or preoccupation with existing or possible disease and/or illness
2. Blooming stage:
   • Illusions of denial of self and body
   • Early delusions re. self and body
3. Chronic stage:
   • Clinical sadness/depression with psychosis
   • Severe, persistent delusions

We’ll share details about these symptoms in a moment. First, we’ll report that current evidence identifies various causes of CS symptoms and conditions associated with CS symptoms.

What Causes Cotard’s Syndrome?

Evidence indicates the possible causes of CS include, but are not limited to:

• Mental/psychiatric disorders:
  • Mood disorders, including depression, bipolar disorder, and depression with psychosis
  • Dissociative disorder
  • Depersonalization disorder
  • Schizophrenia
  • Other disorders with psychosis
• Neurological disorders and/or conditions:
  • Central nervous system (CNS) infections
  • Traumatic brain injury (TBI)
  • Cerebrovascular disease, i.e. injuries, illnesses, or conditions that impair blood flow to the brain, e.g. stroke, aneurysms, brain hemorrhage (bleeding in brain), carotid artery disease
  • CNS neoplasms, i.e. tumors in the brain or in/on the spinal cord
  • Dementia
  • Migraines
  • Encephalopathy
  • Parkinson’s disease

Now let’s take a closer look at the symptoms of CS.

What Are the Most Common Symptoms of Cotard’s Syndrome?

Evidence indicates the possible causes of CS include, but are not limited to:

Cotard’s Syndrome: Symptoms

• Delusions about self/denial of existence of self/body/parts:
  • Belief that body, body parts, identity, and soul do not exist
  • Can lead to absence of self-maintenance, i.e. personal cleanliness
• Total isolation/self-isolation:
  • Associated with/consequence of absence of self-maintenance
• Delusional misidentification:
  • Belief that others – loved ones, friends, etc. – have been replaced with imposters or duplicates, as in Capgras syndrome
  • Associated with denial of self
• Neural dysfunction:
  • Evidence indicates delusions may be the result of problems with/injuries to the amygdala, which connects emotions to facial recognition.
• Derealization:
  • Profound sense of detachment from external world
  • Typically follows dysfunction in facial recognition
• Dissociation with mirror:
  • Person with CS fails to identify or recognize self in mirror
• Delusion/belief that one is dead:
  • Typically follows mirror dissociation/failure to identify self

Note: Symptoms of psychosis in CS may resemble those observed in schizophrenia.

Next, we’ll share the specific factors researchers theorize are associated with the specific symptoms we describe above.

Cotard’s Syndrome: Causal and Associated Factors

• Brain tumors are implicated in the presence of CS symptoms.
• Derealization is associated with delusional misidentification and dissociation with mirror.
• Migraine headaches may cause CS symptoms.
• Severe depression frequently co-occurs with CS
• Damage to the parietal lobe of brain may cause CS symptoms.
• Shrinking/deterioration of frontal lobe may cause CS symptoms.
• Acyclovir and valaciclovir, both antiviral medications, may cause adverse reactions and trigger the onset of CS symptoms. Elevated CMMG, a metabolite of acyclovir and valaciclovir, is associated with presence of CS.

The evidence indicates a wide range of complex and often complementary diseases, disorders, and conditions associated with CS. In some cases, one symptom leads to another, i.e. when failure to identify self in mirror causes a subsequent denial of the existence of oneself, or the belief that one is actually dead. In addition symptoms of psychosis and self-denial can lead to isolation, which itself is a risk factor for escalating depressive symptoms, including psychosis associated with depression.

We’ll close this article with a review of the various evidence-based treatment options for CS.

What Kinds of Treatment Can Help People With Cotard’s Syndrome?

After a thorough review of the available data on evidence-based treatment for CS, the study authors identified the following five (5) effective treatments for CS, which may include various combinations of the treatments listed.

Cotard’s Syndrome: Treatment

1. Pharmacotherapy.
   • Antidepressants such as SSRIs may help decrease symptoms during the initial, or germination stage of CS.
   • Antipsychotics, in combination with SNRIs may help decrease symptoms of CS.
   • In some cases, mood stabilizers may help decrease symptoms of CS.
2. Electroconvulsive Therapy (ECT).
   • Treatment with ECT is the most common and most documented more therapeutic modality for CS, and can help patients with depression with psychosis.
   • For CS patients with lesions in the left hemisphere of the brain and mental illness with psychosis, ECT can function as a first-line treatment.
3. Hemodialysis.
   • For patients with high levels of CMMG – a metabolite of some antiviral medications – kidney dialysis can reduce and/or eliminate CS symptoms.
   • Cognitive-behavioral therapy (CBT) can help CS patients resolve cognitive distortions and reduce symptoms during the second, or blooming, stage of CS.
4. Psychotherapy.
   • Cognitive-behavioral therapy (CBT) can help CS patients resolve cognitive distortions and reduce symptoms during the second, or blooming, stage of CS.
5. Social, medical, and psychological support.
   • A wide range of supportive modalities can help patients manage CS symptoms during the third, or chronic, stage of CS. Experts consider ongoing mental health support as essential during the chronic stage of CS.
6. Multimodal treatment.
   • During the chronic phase, evidence indicates that a mix of medication and psychotherapy is a common approach during the chronic phase of CS.

Like a related disorder, Capgras syndrome, treatment involves addressing the cause of CS symptoms when diagnosis reveals a clear cause, such as a brain lesion or a mental health disorder or neurological condition associated with psychosis. In treatment resistant cases, and/or cases where a clear cause is difficult to identify, evidence shows that supportive, multimodal care is the most effective option.

In closing, we’ll offer the insight of the study authors into the data and evidence related to CS they reviewed for their comprehensive analysis:

“The neurological features, such as misidentification and delusions of negation, shed light on the underlying mechanisms of the disease. ECT, medication, and supportive care are used in combination for treatment, with a focus on the value of ongoing mental health assistance during the illness’s many stages.”